<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/wp-content/plugins/xml-sitemap-feed/assets/sitemap-news.xsl?ver=5.7.7"?>
<!-- generated-on="2026-07-23T01:51:55+00:00" -->
<!-- generator="XML Sitemap & Google News for WordPress" -->
<!-- generator-url="https://status301.net/wordpress-plugins/xml-sitemap-feed/" -->
<!-- generator-version="5.7.7" -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" >
<url><loc>https://diabeticinsieme.it/ema-mounjaro-tirzepatide-indicazione-cardiovascolare-diabete-tipo-2/</loc><news:news><news:publication><news:name>Diabetic Insieme</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-07-23T03:08:08+02:00</news:publication_date><news:title>Mounjaro, l&#8217;EMA non concede l&#8217;indicazione cardiovascolare nel diabete di tipo 2</news:title></news:news></url>
<url><loc>https://diabeticinsieme.it/diabete-tipo-1-cellule-insulina-senza-antirigetto-primo-studio-uomo/</loc><news:news><news:publication><news:name>Diabetic Insieme</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-07-23T03:07:52+02:00</news:publication_date><news:title>Diabete tipo 1, cellule produttrici di insulina senza antirigetto al primo studio sull&#8217;uomo</news:title></news:news></url>
<url><loc>https://diabeticinsieme.it/insulet-omnipod-5-discover-spagna-microinfusore-tubeless/</loc><news:news><news:publication><news:name>Diabetic Insieme</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-07-23T03:07:34+02:00</news:publication_date><news:title>Insulet porta in Spagna il microinfusore senza tubi Omnipod 5 e la piattaforma Omnipod Discover</news:title></news:news></url>
<url><loc>https://diabeticinsieme.it/campagna-mediatica-prevenzione-diabete-tipo-2-hawaii/</loc><news:news><news:publication><news:name>Diabetic Insieme</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-07-23T03:06:56+02:00</news:publication_date><news:title>Diabete tipo 2, una campagna mediatica spinge gli adulti a rischio verso la prevenzione</news:title></news:news></url>
<url><loc>https://diabeticinsieme.it/diabesita-cancro-sid-obesita-rischio-tumori/</loc><news:news><news:publication><news:name>Diabetic Insieme</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-07-22T00:59:06+02:00</news:publication_date><news:title>Diabesità e cancro, la Società Italiana di Diabetologia richiama il rischio oncologico</news:title></news:news></url>
<url><loc>https://diabeticinsieme.it/microrna-due-sottogruppi-diabete-tipo-1-siena/</loc><news:news><news:publication><news:name>Diabetic Insieme</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-07-22T00:58:52+02:00</news:publication_date><news:title>Diabete di tipo 1, da Siena due sottogruppi individuati con i microRNA nel sangue</news:title></news:news></url>
<url><loc>https://diabeticinsieme.it/portal-pump-microinfusore-impiantabile-fda/</loc><news:news><news:publication><news:name>Diabetic Insieme</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-07-22T00:58:38+02:00</news:publication_date><news:title>Portal Pump, il microinfusore di insulina impiantabile ottiene il Breakthrough della FDA</news:title></news:news></url>
<url><loc>https://diabeticinsieme.it/screening-gratuito-diabete-tigullio-asl4/</loc><news:news><news:publication><news:name>Diabetic Insieme</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-07-22T00:58:15+02:00</news:publication_date><news:title>Screening gratuito del diabete nel Tigullio, la Asl 4 apre quattro giornate estive</news:title></news:news></url>
</urlset>
